215 related articles for article (PubMed ID: 24001379)
21. A randomized, double-blinded, placebo-controlled trial of pseudocatalase cream and narrowband ultraviolet B in the treatment of vitiligo.
Bakis-Petsoglou S; Le Guay JL; Wittal R
Br J Dermatol; 2009 Oct; 161(4):910-7. PubMed ID: 19523170
[TBL] [Abstract][Full Text] [Related]
22. Comparison of systemic PUVA and NB-UVB in the treatment of vitiligo: an open prospective study.
Bhatnagar A; Kanwar AJ; Parsad D; De D
J Eur Acad Dermatol Venereol; 2007 May; 21(5):638-42. PubMed ID: 17447977
[TBL] [Abstract][Full Text] [Related]
23. Keratoacanthoma in vitiligo lesion after UVB narrowband phototherapy.
Brazzelli V; Barbagallo T; Prestinari F; Vassallo C; Agozzino M; Vailati F; Cespa M; Borroni G
Photodermatol Photoimmunol Photomed; 2006 Aug; 22(4):211-3. PubMed ID: 16869872
[TBL] [Abstract][Full Text] [Related]
24. Narrowband ultraviolet B phototherapy for patients with refractory uraemic pruritus: a randomized controlled trial.
Ko MJ; Yang JY; Wu HY; Hu FC; Chen SI; Tsai PJ; Jee SH; Chiu HC
Br J Dermatol; 2011 Sep; 165(3):633-9. PubMed ID: 21668425
[TBL] [Abstract][Full Text] [Related]
25. Narrowband UVB phototherapy in skin conditions beyond psoriasis.
Gambichler T; Breuckmann F; Boms S; Altmeyer P; Kreuter A
J Am Acad Dermatol; 2005 Apr; 52(4):660-70. PubMed ID: 15793518
[TBL] [Abstract][Full Text] [Related]
26. Combination of narrow band UVB and topical calcipotriol for the treatment of vitiligo.
Goktas EO; Aydin F; Senturk N; Canturk MT; Turanli AY
J Eur Acad Dermatol Venereol; 2006 May; 20(5):553-7. PubMed ID: 16684283
[TBL] [Abstract][Full Text] [Related]
27. A randomized controlled study of the effects of different modalities of narrow-band ultraviolet B therapy on the outcome of cultured autologous melanocytes transplantation in treating vitiligo.
Zhang DM; Hong WS; Fu LF; Wei XD; Xu AE
Dermatol Surg; 2014 Apr; 40(4):420-6. PubMed ID: 24446755
[TBL] [Abstract][Full Text] [Related]
28. Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trial.
Lim HW; Grimes PE; Agbai O; Hamzavi I; Henderson M; Haddican M; Linkner RV; Lebwohl M
JAMA Dermatol; 2015 Jan; 151(1):42-50. PubMed ID: 25230094
[TBL] [Abstract][Full Text] [Related]
29. Leucine-rich glioma inactivated 3: a novel keratinocyte-derived melanogenic cytokine in vitiligo patients.
Farag AGA; Hammam MA; Al-Sharaky DR; El-Boghdady GM
An Bras Dermatol; 2019; 94(4):434-441. PubMed ID: 31644616
[TBL] [Abstract][Full Text] [Related]
30. Clinical evaluation of interrupted versus continuous narrowband ultraviolet B phototherapy in nonsegmental vitiligo treatment: A prospective randomized comparative study.
Anbar TS; Mohammed SS; Mohamed DM; Abdel-Rahman AT
Dermatol Ther; 2019 Nov; 32(6):e13117. PubMed ID: 31606939
[TBL] [Abstract][Full Text] [Related]
31. Topical calcipotriene and narrowband ultraviolet B in the treatment of vitiligo.
Kullavanijaya P; Lim HW
Photodermatol Photoimmunol Photomed; 2004 Oct; 20(5):248-51. PubMed ID: 15379875
[TBL] [Abstract][Full Text] [Related]
32. Critical evaluation of the variants influencing the clinical response of vitiligo: study of 60 cases treated with ultraviolet B narrow-band phototherapy.
Brazzelli V; Antoninetti M; Palazzini S; Barbagallo T; De Silvestri A; Borroni G
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1369-74. PubMed ID: 17958843
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic evaluation of UVB-targeted phototherapy in vitiligo that affects less than 10% of the body surface area.
Welsh O; Herz-Ruelas ME; Gómez M; Ocampo-Candiani J
Int J Dermatol; 2009 May; 48(5):529-34. PubMed ID: 19416388
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the effects of NB-UVB in both segmental and non-segmental vitiligo affecting different body sites.
Anbar TS; Westerhof W; Abdel-Rahman AT; El-Khayyat MA
Photodermatol Photoimmunol Photomed; 2006 Jun; 22(3):157-63. PubMed ID: 16719871
[TBL] [Abstract][Full Text] [Related]
35. Treatment of vitiligo with broadband ultraviolet B and vitamins.
Don P; Iuga A; Dacko A; Hardick K
Int J Dermatol; 2006 Jan; 45(1):63-5. PubMed ID: 16426381
[TBL] [Abstract][Full Text] [Related]
36. A retrospective study of narrowband-UVB phototherapy for treatment of vitiligo in Malaysian patients.
Adauwiyah J; Suraiya HH
Med J Malaysia; 2010 Dec; 65(4):297-9. PubMed ID: 21901949
[TBL] [Abstract][Full Text] [Related]
37. No additional effect of topical calcipotriol on narrow-band UVB phototherapy in patients with generalized vitiligo.
Ada S; Sahin S; Boztepe G; Karaduman A; Kölemen F
Photodermatol Photoimmunol Photomed; 2005 Apr; 21(2):79-83. PubMed ID: 15752125
[TBL] [Abstract][Full Text] [Related]
38. [Efficacy observation of fire needle combined with narrow band ultraviolet-B (NB-UVB) for vitiligo].
Zhang Y; Chen CT; Huang S; Zhou JW
Zhongguo Zhen Jiu; 2013 Feb; 33(2):121-4. PubMed ID: 23620938
[TBL] [Abstract][Full Text] [Related]
39. Systemic PUVA vs. narrowband UVB in the treatment of vitiligo: a randomized controlled study.
Sapam R; Agrawal S; Dhali TK
Int J Dermatol; 2012 Sep; 51(9):1107-15. PubMed ID: 22909369
[TBL] [Abstract][Full Text] [Related]
40. Narrow-band UVB311 nm vs. broad-band UVB therapy in combination with topical calcipotriol vs. placebo in vitiligo.
Hartmann A; Lurz C; Hamm H; Bröcker EB; Hofmann UB
Int J Dermatol; 2005 Sep; 44(9):736-42. PubMed ID: 16135141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
